Skip to content

Study · Non-randomized trial · n = 80 · 2013

3 results

[Cognitive disorders and their correction in patients with ischemic stroke].

Evzel'man MA, Aleksandrova NA

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2013Cited by 1 (Europe PMC)

PMID24300803 (opens in a new tab)PepBankPUB-24300803

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients after first ischemic stroke, repeated Cortexin courses promoted regression of pronounced movement disorders.

    In plain wordsIn patients after first ischemic stroke, repeated Cortexin courses reduced pronounced movement disorders.

    Outcome
    DecreaseMovement disorders
    Study

    n = 80

    Comparator
    Basic and vascular therapy
    Outcome group
    Exercise and physical function · Nervous system and cognition
    Studied dose
    10 mg once a day · intramuscular · 10 days per course, repeated at 3, 6, 9 months during the yearAs given in this study (human).

    Source sentences

    Summary
    Four-time reception cortexin for a year at 10 mg once a day for 10 days promotes regression pronounced movement disorders, stabilize and restore cognitive function, and minimize the likelihood of post-stroke cognitive impairment during the recovery period.
    2 context sentences
    Summary · context
    The study involved 80 patients first ischemic stroke (IS).
    Summary · context
    The patients of the main group (40 patients) received standard therapy cortexin + 10 mg once a day intramuscularly for 10 days with the same course again at 3, 6, 9 months during the year, the control group (40 people) - basic and vascular therapy for year.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients after first ischemic stroke, repeated Cortexin courses stabilized and restored cognitive function.

    In plain wordsIn patients after first ischemic stroke, repeated Cortexin courses stabilized and restored cognitive function.

    Outcome
    IncreaseCognitive function
    Study

    n = 80

    Comparator
    Basic and vascular therapy
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 mg once a day · intramuscular · 10 days per course, repeated at 3, 6, 9 months during the yearAs given in this study (human).

    Source sentences

    Summary
    Four-time reception cortexin for a year at 10 mg once a day for 10 days promotes regression pronounced movement disorders, stabilize and restore cognitive function, and minimize the likelihood of post-stroke cognitive impairment during the recovery period.
    2 context sentences
    Summary · context
    The study involved 80 patients first ischemic stroke (IS).
    Summary · context
    The patients of the main group (40 patients) received standard therapy cortexin + 10 mg once a day intramuscularly for 10 days with the same course again at 3, 6, 9 months during the year, the control group (40 people) - basic and vascular therapy for year.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients after first ischemic stroke, repeated Cortexin courses reduced the likelihood of cognitive impairment during recovery.

    In plain wordsIn patients after first ischemic stroke, repeated Cortexin courses reduced the likelihood of cognitive impairment during recovery.

    Outcome
    DecreasePost-stroke cognitive impairment likelihood
    Study

    n = 80

    Comparator
    Basic and vascular therapy
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 mg once a day · intramuscular · 10 days per course, repeated at 3, 6, 9 months during the yearAs given in this study (human).

    Source sentences

    Summary
    Four-time reception cortexin for a year at 10 mg once a day for 10 days promotes regression pronounced movement disorders, stabilize and restore cognitive function, and minimize the likelihood of post-stroke cognitive impairment during the recovery period.
    2 context sentences
    Summary · context
    The study involved 80 patients first ischemic stroke (IS).
    Summary · context
    The patients of the main group (40 patients) received standard therapy cortexin + 10 mg once a day intramuscularly for 10 days with the same course again at 3, 6, 9 months during the year, the control group (40 people) - basic and vascular therapy for year.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.